Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Total Current Liabilities (2018 - 2025)

Neurogene (NGNE) has disclosed Total Current Liabilities for 5 consecutive years, with $14.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities fell 6.9% year-over-year to $14.7 million, compared with a TTM value of $14.7 million through Sep 2025, down 6.9%, and an annual FY2024 reading of $15.2 million, changed N/A over the prior year.
  • Total Current Liabilities was $14.7 million for Q3 2025 at Neurogene, down from $15.4 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $15.8 million in Q3 2024 and bottomed at $11.8 million in Q1 2024.